Novartis to acquire The Medicines Company for USD 9.7 bn, adding inclisiran, a potentially transformational investigational cholesterol-lowering therapy to address leading global cause of death

Thomas Shea
Programmatic Marketing

Amy Giles
Increasing Engagement

Matt Turner
Patient Affordability

Frank X. Powers
Healthcare Challenger Brands

Frank Burrell
Scientific Storytelling

Laura Blair
Medication Adherence

Daniel Sontupe
Market Access

Bud Bilanich
Success Coach

Brenda Snow
Authentic Patient Voice

Mike Viscel
Increasing Engagement

Liz Kane
Impactful Strategy

David Linetsky
Patient Activation

Matthew Durham
Omnidynamic Marketing

Paul Theisen
Patient Acquisition

Anil Bhaskar
Unified Customer Experience

Pat Purcell
Meeting Engagement

Stacey Gandler
Brand Nourishment